0001593318-13-000001.txt : 20131203 0001593318-13-000001.hdr.sgml : 20131203 20131203125433 ACCESSION NUMBER: 0001593318-13-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131203 DATE AS OF CHANGE: 20131203 EFFECTIVENESS DATE: 20131203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reset Therapeutics, Inc. CENTRAL INDEX KEY: 0001593318 IRS NUMBER: 711047315 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-207293 FILM NUMBER: 131253842 BUSINESS ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE STREET 2: SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 235-4140 MAIL ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE STREET 2: SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0707 D LIVE 0001593318 Reset Therapeutics, Inc. 260 LITTLEFIELD AVENUE SUITE 200 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 (650) 235-4150 DELAWARE Sircadian, Inc. None Corporation true Ross Bersot 750 Battery Street Suite 400 San Francisco CA CALIFORNIA 94111 Executive Officer Director Frederick B Craves 750 Battery Street Suite 400 San Francisco CA CALIFORNIA 94111 Director Steve Kay c/o Reset Therapeutics, Inc. 260 Littlefield Avenue, Suite 200 South San Francisco CA CALIFORNIA 94080 Director Peter Schultz c/o Reset Therapeutics, Inc. 260 Littlefield Avenue, Suite 200 South San Francisco CA CALIFORNIA 94080 Director Shuichi Kurosaki c/o Reset Therapeutics, Inc. 260 Littlefield Avenue, Suite 200 South San Francisco CA CALIFORNIA 94080 Executive Officer Paul Humphries c/o Reset Therapeutics, Inc. 260 Littlefield Avenue, Suite 200 South San Francisco CA CALIFORNIA 94080 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2013-11-22 false true false 0 15989400 14796231 1193169 false 2 0 0 0 false Reset Therapeutics, Inc. Ross Bersot Ross Bersot President 2013-11-26